Figure 7.
Therapeutic effect of RSV-loaded novel biomimetic nanosystems in vitro. FCM analysis of (A) mitochondrial ROS accumulation obtained by MitoSOX and (B) intracellular H2O2 level by CM-H2DCFDA in Aβ23–35-damaged HT22 cells after treatment with different RSV-loaded formulations. Changes of (C) MnSOD and (D) MDA levels in Aβ23–35-damaged HT22 cells after treatment with different RSV-loaded formulations. (E) Apoptosis results of Aβ23–35-damaged HT22 cells after treatment with different RSV-loaded formulations. The data are presented as the means ± SD (n = 3). * indicates p < 0.05.